Call for Papers
Call for Papers
Abstract submission period: 10:00am, September 30 (Fri.) – 12:00pm, November 25 (Fri.) (Japan Standard Time, UTC+9)
Call for Papers has been closed.
Notification of acceptance or rejection: the mid of February 2023 (tentative)
Type of Presentation
The author can indicate preference on the type of presentation. However, the final decision of presentation style is made by the Program Committee, and your understanding and corporation are highly appreciated.
- Oral
- Poster
- Either will be fine
Abstract submission guidelines
- Once the submission is completed, a confirmation e-mail will be sent automatically. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (E-mail: jspn119@c-linkage.co.jp).
- For changes, withdrawal or additional submission, please contact the Congress Secretariat (E-mail:jspn119@c-linkage.co.jp).
Submission Guideline
Title: up to 100 characters in single byte
Body of abstract: up to 300 words in single byte
Co-authors: up to 30 persons
Affiliations: up to 10 affiliations
Categories
Please choose the category for your paper.
*up to 3 categories can be registered. *you are required to choose at least 1 category.
| 1 | Schizophrenia and related disorders |
|---|---|
| 2 | Mood disorders |
| 3 | Neurotic disorders and related disorders |
| 4 | Personality disorders |
| 5 | Epilepsy |
| 6 | Dementia |
| 7 | Behavioural syndromes associated with physiological disturbances and physical factors |
| 8 | Organic and symptomatic mental disorders |
| 9 | Substance abuse and dependence |
| 10 | Mental disorders in childhood and adolescence |
| 11 | Sleep disorders |
| 12 | Mental retardation |
| 13 | Mental disorders in old age |
| 14 | Forensic psychiatry |
| 15 | Mental health and welfare |
| 16 | Medical education |
| 17 | Psychopathology |
| 18 | Neuropsychology |
| 19 | Neurophysiology |
| 20 | Psychopharmacology |
| 21 | Neurochemistry |
|---|---|
| 22 | Neuropathology |
| 23 | Genetics and molecular genetics |
| 24 | Epidemiology |
| 25 | Community mental health services |
| 26 | Emergency psychiatry |
| 27 | Consultation-liaison psychiatry |
| 28 | Psychiatric diagnosis |
| 29 | Symptomatology |
| 30 | Pharmacotherapy |
| 31 | Psychotherapy |
| 32 | Psychosocial therapy/psychoeducation |
| 33 | ECT/TMS/neuromodulation |
| 34 | Laboratory tests/biomarkers |
| 35 | Neuroimaging |
| 36 | Animal model/basic research |
| 37 | Suicide prevention |
| 38 | Occupational mental health |
| 39 | Social psychiatry |
| 40 | COVID-19 |
| 41 | AI |
| 42 | Treatment-refractory severe mental disorders |
| 43 | Others |
Personal Information Protection
Please read and agree to the "Handling of personal information" in the form.
Inquiry
The 119th Annual Meeting of the Japanese Society of Psychiatry and Neurology
c/o Convention Linkage, Inc.
2 Sanbancho, Chiyoda-ku, Tokyo, 102-0075 Japan
E-mail: jspn119@c-linkage.co.jp
TEL: +81-3-3263-8688 FAX: +81-3-3263-8693
Please download the form, answer the questions, and submit it to the Congress Secretariat by e-mail.